Safety profile of meglumine antimoniate intralesional infiltration for cutaneous leishmaniasis-Reference-Cited by-同舟云学术

Safety profile of meglumine antimoniate intralesional infiltration for cutaneous leishmaniasis

Published:2020-02-24 Issue:4 Volume:18 Page:381-387
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Fernandes Herbert J.¹^ORCID,da Silva Rosiana E.¹,Ramalho Dario B.²,Aguiar Marta G.³,Silveira Josiane N.³,Cota Gláucia¹

Affiliation:

1. Clinical Research and Public Policy Group on Infectious and Parasitic Diseases, Instituto René Rachou, Fundação Oswaldo Cruz – FIOCRUZ, Belo Horizonte, Minas Gerais, Brazil

2. Infectious Diseases Service, Hospital Eduardo de Menezes – FHEMIG, Belo Horizonte, Brazil

3. Department of Pharmaceutical Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2020.1731305

Reference23 articles.

1. Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review

2. Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre

3. Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial

4. Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment

5. Anvisa. Manual para notificação de eventos adversos e monitoramento de segurança em ensaios clínicos. Brazil: Anvisa; 2016. p. 18.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local amphotericin B therapy for Cutaneous Leishmaniasis: A systematic review;PLOS Neglected Tropical Diseases;2024-04-16

2. Intralesional Antimonial Drug Treatment for Leishmania braziliensis Cutaneous Leishmaniasis: The Knowns and the Unknowns;Clinical Infectious Diseases;2023-04-26

3. Cardiovascular Effects of Environmental Metal Antimony: Redox Dyshomeostasis as the Key Pathogenic Driver;Antioxidants & Redox Signaling;2023-04-01

4. Alteraciones electrocardiográficas por Glucantime® intralesional, un evento adverso potencialmente grave;Actas Dermo-Sifiliográficas;2022-07

5. [Translated article] Electrocardiographic Alterations Related to Intralesional Glucantime® Treatments: A Potentially Severe Adverse Event;Actas Dermo-Sifiliográficas;2022-07